1-2 of 2
Jaime Perez-Oteyza
Close
Sort by
Journal Articles

Myelodysplastic Syndromes with I(17)(q10) and Prognostic Implications of Mutations of TP53 and SETBP1

Vera Adema, PhDstudent, Larrayoz Maria Jose, Calasanz Maria Jose, PhD, Laura Palomo, PhDstudent, Ana Patiño-Garcia, MD PhD, Xabier Aguirre, PhD, Jesús María Hernández-Rivas, MD PhD, Eva Lumbreras, Ismael Buno, PhD, Carolina Martínez-Laperche, PhD, Mar Mallo, PhD, Olga Garcia, Paula Gomez-Marzo, Sara Alvarez, MD PhD, Beatriz Blazquez, Jose Cervera, MD, Elisa Luño, Alberto Valiente, Teresa Vallespi, MD PhD, Ana Vicente, Leonor Arenillas, MD, Rosa Collado, PhD, Jaime Perez-Oteyza, Francesc Sole, PhD
Journal: Blood
Blood (2014) 124 (21): 1910.
https://doi.org/10.1182/blood.V124.21.1910.1910
Published: 2014
Journal Articles

Is Azacitidine (AZA) Really Effective in High Risk MDS Patients with Chromosome 7 Abnormalities (Abn 7)? Results of a Retrospective Study From the GFM and GESMD Registries

María Díez-Campelo, MD, PhD, Raphael Itzykson, Silvia M Rojas, Céline Berthon, MD, PhD, Elisa Luño, Odile Beyne-Rauzy, Jaime Perez-Oteyza, Norbert Vey, MD, PhD, Joan Bargay, Sophie Park, Teresa Cedena, Dominique Bordessoule, MD, PhD, Juan A Muñoz, Emmanuel Gyan, MD, PhD, Esperanza Such, Sorin Visanica, MD, Luis Benlloch, Stéphane de Botton, MD, PhD, Jesús M Hernández-Rivas, Shanti Ame, MD, Aspasia Stamatoullas, MD, Jacques Delaunay, MD, Celia Salanoubat, MD, Françoise Isnard, MD, Guillermo Sanz, Romain Guieze, MD, Consuelo Cañizo, MD, PhD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1713.
https://doi.org/10.1182/blood.V120.21.1713.1713
Published: 2012